Anastasia S. Yasneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anastasia S. Yasneva has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Daria Strelkova
Department of Hospital Therapy #2, I.M. Sechenov First Moscow State Medical University, Moscow, Russia, mma.ru
3 shared publications - Lyudmila V. Fedina
Russian Medical Academy of Continuous Professional Education
3 shared publications - Nataliia Ananicheva
Regional Vascular Center, City Clinical Hospital named after S. S. Yudin, Moscow, Russia
3 shared publications - Svetlana Aleksandrovna Rachina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Anna Egorovna Vlasenko
Samara State Medical University of the Ministry of Health of the Russian Federation
2 shared publications - F. Yu. Kopylov
Department of Cardiology, Functional and Ultrasound Diagnostics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia
2 shared publications
Latest Publications
- 17 June 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (2) , 204-212
Left ventricular non-compaction in an athlete: a clinical case with sudden manifestation
Left ventricular non-compaction cardiomyopathy is a rare genetically determined phenomenon associated with impaired myocardial compaction and the risk of developing chronic heart failure, ventricular arrhythmias, and thromboembolism. This report presents the case of a 26-year-old professional boxer, previously considered healthy, who developed edema, progressive dyspnea, and syncope after COVID-19, leading to hospitalisation. Echocardiography revealed chamber dilation, left ventricular wall hypertrabeculation, a noncompacted-to-compacted layer ratio greater than two to one, and a left ventricular ejection fraction of 21 to 28 percent. Contrast-enhanced magnetic resonance imaging confirmed left ventricular noncompaction cardiomyopathy (noncompacted myocardial mass of 23% according to the А. Jacquier et al. criterion) and signs of fibrosis. Treatment was initiated with quadruple therapy for chronic heart failure, diuretics, and rivaroxaban; no thromboembolic events were recorded. On optimal therapy, the left ventricular ejection fraction improved to 44% by November 2025, symptoms significantly regressed, and the patient returned to non-professional training. The case of detecting left ventricular non-compaction syndrome in an athlete is particularly interesting due to the complexity of differentiating between the physiological hypertrophy of an "athlete’s heart" and the excessive trabeculation and non-compaction of the left ventricular myocardium seen in left ventricle non’compaction. Intense training most likely contributed to the functional maladaptation of the left ventricle, and a prior viral infection may have served as a triggering factor in a morphologically altered heart, leading to the subsequent transition to cardiomyopathy against a background of genetic predisposition.
- 17 June 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 22 (2) , 204-212
Left ventricular non-compaction in an athlete: a clinical case with sudden manifestation
Left ventricular non-compaction cardiomyopathy is a rare genetically determined phenomenon associated with impaired myocardial compaction and the risk of developing chronic heart failure, ventricular arrhythmias, and thromboembolism. This report presents the case of a 26-year-old professional boxer, previously considered healthy, who developed edema, progressive dyspnea, and syncope after COVID-19, leading to hospitalisation. Echocardiography revealed chamber dilation, left ventricular wall hypertrabeculation, a noncompacted-to-compacted layer ratio greater than two to one, and a left ventricular ejection fraction of 21 to 28 percent. Contrast-enhanced magnetic resonance imaging confirmed left ventricular noncompaction cardiomyopathy (noncompacted myocardial mass of 23% according to the А. Jacquier et al. criterion) and signs of fibrosis. Treatment was initiated with quadruple therapy for chronic heart failure, diuretics, and rivaroxaban; no thromboembolic events were recorded. On optimal therapy, the left ventricular ejection fraction improved to 44% by November 2025, symptoms significantly regressed, and the patient returned to non-professional training. The case of detecting left ventricular non-compaction syndrome in an athlete is particularly interesting due to the complexity of differentiating between the physiological hypertrophy of an "athlete’s heart" and the excessive trabeculation and non-compaction of the left ventricular myocardium seen in left ventricle non’compaction. Intense training most likely contributed to the functional maladaptation of the left ventricle, and a prior viral infection may have served as a triggering factor in a morphologically altered heart, leading to the subsequent transition to cardiomyopathy against a background of genetic predisposition.
- Open Access
- 1 January 2026
- Published by Wiley in Pulmonary Medicine
- Vol. 2026 (1) , e8552717
Distinguishing Between Bacterial and Viral Community‐Acquired Pneumonia in Hospitalized Adults: The Importance of Clinical, Laboratory, and Imaging Findings
Background: Our study aims to compare patients with identified viral and bacterial pathogens and develop a predictive model for determining community‐acquired pneumonia (CAP) etiology. Methods: In this retrospective case–control study, hospitalized adults with confirmed bacterial or viral CAP were compared at a 1:3 ratio. Patients were matched by gender, hospitalization department, age, and Charlson comorbidity index. The etiology of CAP was established through blood and sputum culture, polymerase chain reaction of respiratory specimens, and urinary antigen tests. Both objective variables and subjective symptoms were assessed using multivariate conditional logistic regression. Results: Our study included 400 patients. Using the best‐developed model, we found that patients with bacterial CAP were more likely to exhibit unilateral infiltration on visualization (odds ratio [OR] 20.47; 95% confidence intervals [CI; 7.51–55.81], p < 0.001), experience chills (OR 20.69; 95% CI [6.08–70.38], p < 0.001), have a higher heart rate (OR 1.04; 95% CI [1.01–1.06], p = 0.001), and demonstrate an elevated neutrophils/lymphocytes ratio (OR 1.58; 95% CI [1.16–2.14], p = 0.003). They also showed a decreased level of consciousness (OR 3.16; [1.16–8.61], p = 0.024), and were more likely to receive vasopressors within the first 24 h of admission (OR 8.28; 95% CI [1.75–39.22], p = 0.008). Conversely, they were less likely to have general weakness (OR 0.20; 95% CI [0.09–0.47], p < 0.001) and tended to have lower total serum protein levels (OR 0.06; 95% CI [0.01–0.45], p = 0.006). This model showed sensitivity of 90%, specificity of 91%, and positive predictive value of 97%. Conclusion: The developed model offers a valuable tool for assessing the etiology of CAP upon admission.
- 1 January 2026
- Published by Wiley in Pulmonary Medicine
- Vol. 2026 (1) , e8552717
Open AccessDistinguishing Between Bacterial and Viral Community‐Acquired Pneumonia in Hospitalized Adults: The Importance of Clinical, Laboratory, and Imaging Findings
Background: Our study aims to compare patients with identified viral and bacterial pathogens and develop a predictive model for determining community‐acquired pneumonia (CAP) etiology. Methods: In this retrospective case–control study, hospitalized adults with confirmed bacterial or viral CAP were compared at a 1:3 ratio. Patients were matched by gender, hospitalization department, age, and Charlson comorbidity index. The etiology of CAP was established through blood and sputum culture, polymerase chain reaction of respiratory specimens, and urinary antigen tests. Both objective variables and subjective symptoms were assessed using multivariate conditional logistic regression. Results: Our study included 400 patients. Using the best‐developed model, we found that patients with bacterial CAP were more likely to exhibit unilateral infiltration on visualization (odds ratio [OR] 20.47; 95% confidence intervals [CI; 7.51–55.81], p < 0.001), experience chills (OR 20.69; 95% CI [6.08–70.38], p < 0.001), have a higher heart rate (OR 1.04; 95% CI [1.01–1.06], p = 0.001), and demonstrate an elevated neutrophils/lymphocytes ratio (OR 1.58; 95% CI [1.16–2.14], p = 0.003). They also showed a decreased level of consciousness (OR 3.16; [1.16–8.61], p = 0.024), and were more likely to receive vasopressors within the first 24 h of admission (OR 8.28; 95% CI [1.75–39.22], p = 0.008). Conversely, they were less likely to have general weakness (OR 0.20; 95% CI [0.09–0.47], p < 0.001) and tended to have lower total serum protein levels (OR 0.06; 95% CI [0.01–0.45], p = 0.006). This model showed sensitivity of 90%, specificity of 91%, and positive predictive value of 97%. Conclusion: The developed model offers a valuable tool for assessing the etiology of CAP upon admission.
- 20 November 2024
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 30 (5) , 494-504
Blood pressure monitoring using telemedicine technologies in patients with chronic heart failure
Continuous monitoring of cardiovascular patients is one of the most important tasks in modern cardiology. Monitoring chronic heart failure (CHF) patients is critical because of instability, high prevalence and life-threatening nature of this disease. Currently, active search and development of optimal devices and programs for medical telemonitoring continues. This review presents the results of Russian and foreign studies on the use of invasive and non-invasive technologies for monitoring blood pressure (BP) levels and demonstrates their clinical significance. Innovative cuffed and cuffless BP monitoring devices are evaluated. The effectiveness of hypertension and CHF management using remote monitoring is compared with standard practice. The relationship between the risk of hospitalization for CHF and the monitoring is demonstrated. The paper presents data on the cost-effectiveness of using telemedicine technologies such as BP monitoring for CHF management.
- 20 November 2024
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 30 (5) , 494-504
Blood pressure monitoring using telemedicine technologies in patients with chronic heart failure
Continuous monitoring of cardiovascular patients is one of the most important tasks in modern cardiology. Monitoring chronic heart failure (CHF) patients is critical because of instability, high prevalence and life-threatening nature of this disease. Currently, active search and development of optimal devices and programs for medical telemonitoring continues. This review presents the results of Russian and foreign studies on the use of invasive and non-invasive technologies for monitoring blood pressure (BP) levels and demonstrates their clinical significance. Innovative cuffed and cuffless BP monitoring devices are evaluated. The effectiveness of hypertension and CHF management using remote monitoring is compared with standard practice. The relationship between the risk of hospitalization for CHF and the monitoring is demonstrated. The paper presents data on the cost-effectiveness of using telemedicine technologies such as BP monitoring for CHF management.
- 1 September 2024
- Published by MEDIKON LLC in Comorbidity neurology
- Vol. 1 (3)
Legionnaires' Disease with Neurological Manifestations: Case Report
INTRODUCTION. Legionnaires' disease may be manifested by neurological symptoms along with lung damage. Cerebellar ataxia and dysarthria are rare extrapulmonary manifestations of legionellosis. These symptoms significantly reduce the quality of life of patients. AIM. To analyze the literature data on neurological manifestations of legionellosis and to present a clinical case of Legionnaires' disease manifestation with neurological symptoms. MATERIAL AND METHODS. We performed an analysis of the available literature. Twenty-four Russian and international literature sources (PubMed databases) were evaluated, describing the characteristics and prevalence of neurological manifestations in Legionnaires' disease. We also described the main theories of the pathogenesis of these clinical manifestations. Our clinical case is presented. RESULTS AND DISCUSSION. As of today, few cases of Legionnaires' disease with cerebellar symptoms have been described. Dysarthria and ataxia are the most frequent manifestations of cerebellar dysfunction in legionellosis. Cases where neurologic symptoms persisted after the resolution of pneumonia have been described previously. There are also reports of manifestation of Legionnaires' disease with cerebellar ataxia. The pathophysiology of cerebellar involvement is unknown. There are hypotheses of toxin-mediated and immune-mediated mechanisms. Recent studies have shown that L. pneumophila can activate receptors responsible for enacting the inflammasome pathway. This mechanism promotes cell death that occurs to remove the intracellular pathogen, which may be responsible for central nervous system dysfunction. CASE PRESENTATION. A 48-year-old woman was hospitalized with a suspected stroke. She works in diamond production and is in contact with aerosolized liquids. Four days before hospitalization she complained of a headache, and in the evening before she lost consciousness. Slurred speech, unsteadiness, and inability to walk were noted. At hospitalization, no instrumental evidence of stroke was obtained. Inflammatory markers were elevated. Chest computer tomography showed infiltrative changes. The rapid test for antigenuria (L. pneumophila) was positive, and community-acquired legionellosis was confirmed. Levofloxacin was administrated. After discharge, dysarthria, dysphagia, and instability in the Romberg pose persisted. CONCLUSION. The example of this clinical observation demonstrates that in rare cases Legionnaires' disease can manifest as other diseases, which requires a certain vigilance of doctors of different specialities in order to timely diagnose the disease. KEYWORDS: Legionnaires' disease, legionellosis, community-acquired pneumonia, central nervous system, infectious disease
- 1 September 2024
- Published by MEDIKON LLC in Comorbidity neurology
- Vol. 1 (3)
Legionnaires' Disease with Neurological Manifestations: Case Report
INTRODUCTION. Legionnaires' disease may be manifested by neurological symptoms along with lung damage. Cerebellar ataxia and dysarthria are rare extrapulmonary manifestations of legionellosis. These symptoms significantly reduce the quality of life of patients. AIM. To analyze the literature data on neurological manifestations of legionellosis and to present a clinical case of Legionnaires' disease manifestation with neurological symptoms. MATERIAL AND METHODS. We performed an analysis of the available literature. Twenty-four Russian and international literature sources (PubMed databases) were evaluated, describing the characteristics and prevalence of neurological manifestations in Legionnaires' disease. We also described the main theories of the pathogenesis of these clinical manifestations. Our clinical case is presented. RESULTS AND DISCUSSION. As of today, few cases of Legionnaires' disease with cerebellar symptoms have been described. Dysarthria and ataxia are the most frequent manifestations of cerebellar dysfunction in legionellosis. Cases where neurologic symptoms persisted after the resolution of pneumonia have been described previously. There are also reports of manifestation of Legionnaires' disease with cerebellar ataxia. The pathophysiology of cerebellar involvement is unknown. There are hypotheses of toxin-mediated and immune-mediated mechanisms. Recent studies have shown that L. pneumophila can activate receptors responsible for enacting the inflammasome pathway. This mechanism promotes cell death that occurs to remove the intracellular pathogen, which may be responsible for central nervous system dysfunction. CASE PRESENTATION. A 48-year-old woman was hospitalized with a suspected stroke. She works in diamond production and is in contact with aerosolized liquids. Four days before hospitalization she complained of a headache, and in the evening before she lost consciousness. Slurred speech, unsteadiness, and inability to walk were noted. At hospitalization, no instrumental evidence of stroke was obtained. Inflammatory markers were elevated. Chest computer tomography showed infiltrative changes. The rapid test for antigenuria (L. pneumophila) was positive, and community-acquired legionellosis was confirmed. Levofloxacin was administrated. After discharge, dysarthria, dysphagia, and instability in the Romberg pose persisted. CONCLUSION. The example of this clinical observation demonstrates that in rare cases Legionnaires' disease can manifest as other diseases, which requires a certain vigilance of doctors of different specialities in order to timely diagnose the disease. KEYWORDS: Legionnaires' disease, legionellosis, community-acquired pneumonia, central nervous system, infectious disease
- Open Access
- 1 August 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4070
Hematologic mask of infective endocarditis as a cause of fever of unknown origin: a case report
Fever of unknown origin (FUO), despite the wide diagnostic potential of modern medicine, remains a difficult problem for clinicians. Often, making a correct diagnosis requires a comprehensive examination of the patient, as well as the joint work of doctors from different specialties. A 57-year-old male patient was hospitalized due to an episode of loss of consciousness, unmotivated weight loss and daily evening temperature rises to 38-39 о C, accompanied by chills and increased sweating. Previously, he was examined by a general practitioner, a cardiologist, and repeatedly by a hematologist. There was no evidence of an infectious disease, arrhythmias, multiple myeloma, lymphoproliferative disorders. Monoclonal gammopathy of undetermined significance (MGUS) was diagnosed. Blood tests revealed neutrophilia (9800 cells/ μl) and moderate anemia. The patient was hospitalized to determine the FUO cause. Heart auscultation revealed a systolic murmur in the mitral valve, which was previously absent. Echocardiography revealed a mobile masses on the mitral valve, severe mitral regurgitation, and therefore infective endocarditis was diagnosed. Empirical antibiotic therapy with ceftriaxone and levofloxacin was administered. Further blood culture revealed growth of a HACEK representative Aggregatibacter actinomycetemcomitans , sensitive to both drugs. Examination established the odontogenic nature of endocarditis. During treatment, stable normothermia and significant blood count improvement were achieved. However, fluoroquinolone therapy led to tendinopathy. Due to persistent grade 3 mitral regurgitation, the patient underwent routine mitral valve replacement. Further follow-up revealed satisfactory condition of the patient. A feature of this case is the atypical course of infective endocarditis, occurring under a hematological mask, which made its diagnosis difficult. When examining a FUO patient, infective endocarditis should be included in the range of possible causes, taking into account not only the typical clinical picture, but also the numerous masks of this disease.
- 1 August 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (8) , 4070
Open AccessHematologic mask of infective endocarditis as a cause of fever of unknown origin: a case report
Fever of unknown origin (FUO), despite the wide diagnostic potential of modern medicine, remains a difficult problem for clinicians. Often, making a correct diagnosis requires a comprehensive examination of the patient, as well as the joint work of doctors from different specialties. A 57-year-old male patient was hospitalized due to an episode of loss of consciousness, unmotivated weight loss and daily evening temperature rises to 38-39 о C, accompanied by chills and increased sweating. Previously, he was examined by a general practitioner, a cardiologist, and repeatedly by a hematologist. There was no evidence of an infectious disease, arrhythmias, multiple myeloma, lymphoproliferative disorders. Monoclonal gammopathy of undetermined significance (MGUS) was diagnosed. Blood tests revealed neutrophilia (9800 cells/ μl) and moderate anemia. The patient was hospitalized to determine the FUO cause. Heart auscultation revealed a systolic murmur in the mitral valve, which was previously absent. Echocardiography revealed a mobile masses on the mitral valve, severe mitral regurgitation, and therefore infective endocarditis was diagnosed. Empirical antibiotic therapy with ceftriaxone and levofloxacin was administered. Further blood culture revealed growth of a HACEK representative Aggregatibacter actinomycetemcomitans , sensitive to both drugs. Examination established the odontogenic nature of endocarditis. During treatment, stable normothermia and significant blood count improvement were achieved. However, fluoroquinolone therapy led to tendinopathy. Due to persistent grade 3 mitral regurgitation, the patient underwent routine mitral valve replacement. Further follow-up revealed satisfactory condition of the patient. A feature of this case is the atypical course of infective endocarditis, occurring under a hematological mask, which made its diagnosis difficult. When examining a FUO patient, infective endocarditis should be included in the range of possible causes, taking into account not only the typical clinical picture, but also the numerous masks of this disease.
- Open Access
- 2 May 2024
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 96 (4) , 386-390
Remote electrocardiogram monitoring in cancer patients for detecting cardiotoxicity. Case report
Cardiotoxicity is the direct adverse effect of anticancer agents on the function or structure of the heart, occurring both during treatment and many years later. The manifestations of cardiotoxicity can be very different: heart failure, coronary heart disease, cardiomyopathy, myocarditis, pericarditis, and arrhythmias, including atrial fibrillation (AF). The incidence of AF in the cancer patient population during therapy is 20–30%. Current options of remote electrocardiogram monitoring ensure the timely detection and treatment of AF in cancer patients, including the administration of anticoagulants. The article presents a clinical case of a 59-year-old patient with squamous cell carcinoma of the lower third of the esophagus after the first course of the TPF polychemotherapy regimen (docetaxel, cisplatin, 5-fluorouracil) with AF detected using a single-channel electrocardiogram monitor in a smartphone case.
- 2 May 2024
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 96 (4) , 386-390
Open AccessRemote electrocardiogram monitoring in cancer patients for detecting cardiotoxicity. Case report
Cardiotoxicity is the direct adverse effect of anticancer agents on the function or structure of the heart, occurring both during treatment and many years later. The manifestations of cardiotoxicity can be very different: heart failure, coronary heart disease, cardiomyopathy, myocarditis, pericarditis, and arrhythmias, including atrial fibrillation (AF). The incidence of AF in the cancer patient population during therapy is 20–30%. Current options of remote electrocardiogram monitoring ensure the timely detection and treatment of AF in cancer patients, including the administration of anticoagulants. The article presents a clinical case of a 59-year-old patient with squamous cell carcinoma of the lower third of the esophagus after the first course of the TPF polychemotherapy regimen (docetaxel, cisplatin, 5-fluorouracil) with AF detected using a single-channel electrocardiogram monitor in a smartphone case.
- Open Access
- 28 February 2024
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4,p. 78-85
Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients
Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance. Aim. Development of a model for differentiating community-acquired bacterial pneumonia and viral lung injury, including COVID-19. Materials and methods. This retrospective case–control study included 300 adult patients with viral lung injury and 100 adult patients with community-acquired bacterial pneumonia. Clinical, laboratory, and instrumental data were analyzed, significant factors were selected by which the samples differed, and a model was developed using logistic regression to distinguish between community-acquired bacterial pneumonia and viral lung damage, including COVID-19. Results. The developed model included the following parameters: total protein level, neutrophil/lymphocyte index, heart rate, unilateral infiltration on CT or chest x-ray, vasopressor prescription in the first 24 h of hospitalization, altered level of consciousness, chills, and fatigue. The model had the following characteristics: AUC = 0.94 (0.92–0.96), AUC_PR = 0.84 (0.76 to 0.92), prediction accuracy — 90%, sensitivity — 76%, specificity — 95%, positive predictive value — 83 %. Conclusion. The use of this model can facilitate the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury, including COVID-19, in adults in general wards and intensive care units.
- 28 February 2024
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4,p. 78-85
Open AccessDevelopment of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients
Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance. Aim. Development of a model for differentiating community-acquired bacterial pneumonia and viral lung injury, including COVID-19. Materials and methods. This retrospective case–control study included 300 adult patients with viral lung injury and 100 adult patients with community-acquired bacterial pneumonia. Clinical, laboratory, and instrumental data were analyzed, significant factors were selected by which the samples differed, and a model was developed using logistic regression to distinguish between community-acquired bacterial pneumonia and viral lung damage, including COVID-19. Results. The developed model included the following parameters: total protein level, neutrophil/lymphocyte index, heart rate, unilateral infiltration on CT or chest x-ray, vasopressor prescription in the first 24 h of hospitalization, altered level of consciousness, chills, and fatigue. The model had the following characteristics: AUC = 0.94 (0.92–0.96), AUC_PR = 0.84 (0.76 to 0.92), prediction accuracy — 90%, sensitivity — 76%, specificity — 95%, positive predictive value — 83 %. Conclusion. The use of this model can facilitate the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury, including COVID-19, in adults in general wards and intensive care units.
- Open Access
- 7 July 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (7) , 5481
Pulmonary hypertension and right ventricular dysfunction as predictors of severe coronavirus infection
Coronavirus disease 2019 (COVID-19) is a disease characterized by diverse clinical manifestations, the severity of which can vary from asymptomatic to extremely severe. At this stage, the urgent task is the early detection of reliable markers of its severity in the acute period of infection and possible changes that cause symptoms in the post-COVID period. The severe COVID-19 is associated with extensive damage to the lungs, pulmonary vessels, and cardiovascular system. In this regard, it seems natural to study the problem of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in patients with COVID-19, and their significance for assessing the severity of the condition and prognosis. Also important is the availability of reliable non-invasive diagnostics. This review presents data on the incidence of PH and RVD and their potential significance in patients with COVID-19. We have analyzed literature sources in the eLIBRARY, PubMed/MEDLINE, ScienceDirect and ProQuest databases.
- 7 July 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 28 (7) , 5481
Open AccessPulmonary hypertension and right ventricular dysfunction as predictors of severe coronavirus infection
Coronavirus disease 2019 (COVID-19) is a disease characterized by diverse clinical manifestations, the severity of which can vary from asymptomatic to extremely severe. At this stage, the urgent task is the early detection of reliable markers of its severity in the acute period of infection and possible changes that cause symptoms in the post-COVID period. The severe COVID-19 is associated with extensive damage to the lungs, pulmonary vessels, and cardiovascular system. In this regard, it seems natural to study the problem of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in patients with COVID-19, and their significance for assessing the severity of the condition and prognosis. Also important is the availability of reliable non-invasive diagnostics. This review presents data on the incidence of PH and RVD and their potential significance in patients with COVID-19. We have analyzed literature sources in the eLIBRARY, PubMed/MEDLINE, ScienceDirect and ProQuest databases.